Abstract
Cardiorenal syndromes are broadly defined as disorders of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. The syndromes represent the intersection and overlap of two very common conditions facing practitioners, and an understanding of the complex bidirectional interactions of these organ systems is paramount for their management. In this chapter, we focus on the common situation whereby patients with acute decompensated heart failure or acute coronary syndrome experience abrupt worsening of kidney function known as acute kidney injury. This has been termed acute cardiorenal syndrome. This chapter reviews the definition, epidemiology, pathophysiology, manifestations, and treatment of acute cardiorenal syndrome, highlighting the need for further breakthroughs in management of this condition.
Keywords
cardiorenal syndrome, acute kidney injury, heart failure, acute decompensated heart failure, acute coronary syndrome
Cardiorenal syndromes are broadly defined as disorders of the heart and kidneys, whereby acute or chronic dysfunction in one organ induces acute or chronic dysfunction of the other. The syndromes represent the intersection and overlap of two very common conditions, heart disease and kidney disease, and an understanding of the complex bidirectional interactions of these organ systems is paramount for their management.
In this chapter, we focus on the common situation whereby patients with acute decompensated heart failure (ADHF) or acute coronary syndrome (ACS) experience abrupt worsening of kidney function known as acute kidney injury (AKI). This is termed acute cardiorenal syndrome (CRS). Other types of CRS include a more indolent form of chronic kidney disease arising in patients with longer term heart failure, termed chronic CRS. This and additional subtypes are highlighted in Box 29.1 but are not discussed in this chapter.
Cardiorenal Syndromes
General Definition
Disorders of the heart and kidneys, whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other
Acute CRS (Type 1)
Acute worsening of cardiac function leading to kidney dysfunction
Chronic CRS (Type 2)
Chronic abnormalities in cardiac function leading to kidney dysfunction
Acute Renocardiac Syndrome (Type 3)
Acute worsening of kidney function causing cardiac dysfunction
Chronic Renocardiac Syndrome (Type 4)
Chronic abnormalities in kidney function leading to cardiac disease
Secondary CRS (Type 5)
Systemic conditions causing simultaneous dysfunction of the heart and kidney
CRS , Cardiorenal syndrome.
Definition and Epidemiology of Acute Cardiorenal Syndrome
Acute CRS is defined as an acute worsening of cardiac function leading to kidney dysfunction. ADHF can represent acute presentation of de novo heart failure or, more frequently, acute decompensation of chronic heart failure and typically is characterized by rapid worsening of the typical signs and symptoms of heart failure (shortness of breath, pulmonary rales, congestion on chest radiograph, raised jugular venous pressure, and peripheral edema), as highlighted in Box 29.2 and Table 29.1 . However, heart failure is a heterogeneous condition with various clinical presentations and multiple contributing factors. Although depressed left ventricular function is an important feature of heart failure, many patients presenting with ADHF have preserved left ventricular ejection fraction, and in roughly one-third of patients, ACS precipitates the decompensation. Accordingly, the hemodynamic derangements found in patients with ADHF are highly variable and to certain degrees overlapping, potentially including acute pulmonary edema with hypertension, severe peripheral fluid overload, isolated severe right heart failure with hepatic congestion, ascites and edema, cardiogenic shock, hypotension, and so on ( Fig. 29.1 ). The European Society of Cardiology (ESC) schematic for characterizing patients based on presence or absence of congestion (“wet” or “dry”) and hypoperfusion (“cold” or “warm”) is depicted in Table 29.2 . In addition, Table 29.3 lists the ESC diagnostic criteria and presenting clinical phenotypes of the various heart-failure syndromes as relating to reduction or preservation of ejection fraction.
Heart failure is a clinical syndrome in which patients have the following features:
- •
Symptoms typical of heart failure
- •
Breathlessness at rest or on exercise, fatigue, tiredness
- •
- •
Signs typical of heart failure
- •
Tachycardia, tachypnea, pulmonary rales, pleural effusion, raised jugular venous pressure, peripheral edema, hepatomegaly
- •
- •
Objective evidence of a structural or functional abnormality of the heart at rest
- •
Cardiomegaly, third heart sound, cardiac murmurs, abnormality on echocardiogram, raised concentration of natriuretic peptide
- •
Dominant Clinical Features | Symptoms | Signs |
---|---|---|
Peripheral edema/congestion | Breathlessness Tiredness, fatigue Anorexia | Peripheral edema Raised jugular venous pressure Pulmonary edema Hepatomegaly, ascites Fluid overload (congestion) Cachexia |
Pulmonary edema | Severe breathlessness at rest | Pulmonary crackles, effusion Tachycardia, tachypnea |
Cardiogenic shock (low cardiac output state) | Confusion Weakness Cold periphery | Poor peripheral perfusion Systolic blood pressure less than 90 mm Hg Anuria or oliguria |
High blood pressure (hypertensive heart failure) | Breathlessness | Usually elevated blood pressure Left ventricular hypertrophy Preserved ejection fraction |
Right heart failure | Breathlessness Fatigue | Evidence of right ventricular dysfunction Raised jugular venous pulsation Peripheral edema, hepatomegaly |
Congestion Absent | Congestion Absent | |
---|---|---|
Hypoperfusion absent | Warm-Dry | Warm-Wet |
Hypoperfusion present | Cold-Dry | Cold-Wet |
Type of HF | HFrEF | HFmrEF | HFpEF |
---|---|---|---|
Criteria | Symptoms ± signs | Symptoms ± signs | Symptoms ± signs |
LV ejection fraction <40% | LV ejection fraction 40%–49% | LV ejection fraction ≥50% | |
Elevated natriuretic peptides | Elevated natriuretic peptides | ||
Structural heart disease and/or diastolic dysfunction | Structural heart disease and/or diastolic dysfunction |